Scientists have developed an antibody that significantly suppresses malignant tumours in dogs.
Researchers from Hokkaido University in Japan developed c4G12, a “chimeric anti-PD-L1 antibody”, that induces immune responses and therefore tumour regression in dogs with malignant cancers.
A pilot clinical study was performed on seven dogs with oral malignant melanoma. One of the dogs showed obvious tumour regression after 10 weeks of administration, said the study published in the journal Scientific Reports .
Source: The Hindu